Hospital Pablo Tobón Uribe
Hospital Pablo Tobón Uribe
CL 78B #69 - 240, Cordoba, Medellín, Robledo, Medellín, Antioquia, Colombia
Select an option
I am a doctor
I am a sponsor
Specializations
Our team
Medical staff
Jhon Jaime Carvajal Gutierrez
Ivan Dario Jaramillo
Gabriel Mosquera
Kelly Johanna Franco
Javier Dario Marquez
Ana Maria Gonzalez
Open studies
Invasive Candidiasis
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. - Basilea PharmaceuticaSee more
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. - Basilea PharmaceuticaSee more
Non-Hodgkin Lymphoma
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) - waveLINE-003 - Merck Sharp & Dohme LLCSee more
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) - waveLINE-010 - Merck Sharp & Dohme LLCSee more
Lupus
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis - SOLUNA - Hoffmann-La RocheSee more
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis - SOLUNA - Hoffmann-La RocheSee more
Crohn's disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease - STARSCAPE-1 - SanofiSee more
Solid tumors
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) - LIGHTBEAM-U01 - Merck Sharp & Dohme LLCSee more
